Skip to main content
Erschienen in: Acta Neurologica Belgica 3/2018

23.05.2018 | Original Article

Sensory neuropathic symptoms in idiopathic Parkinson’s disease: prevalence and impact on quality of life

verfasst von: Joy K. Adewusi, Marios Hadjivassiliou, Ana Vinagre-Aragón, Karen Ruth O’Connor, Aijaz Khan, Richard Adam Grünewald, Panagiotis Zis

Erschienen in: Acta Neurologica Belgica | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Neuropathic symptoms are commonly reported in Parkinson’s disease (PD), but robust data on the epidemiology of such symptoms are lacking. The present study sought to investigate the prevalence and determinants of peripheral sensory neuropathic symptoms (PSNS) in idiopathic PD (IPD) and ascertain the effects of such symptoms on the patients’ quality of life (QoL).

Methods

Patients with IPD and age-matched and gender-matched controls were screened for neuropathic symptoms using the Michigan Neuropathy Screening Instrument. The impact of neuropathic symptoms on QoL was investigated using the 36-Item Short Form Survey.

Results

Fifty-two patients and 52 age-matched and gender-matched controls were recruited. PSNS were reported more frequently in patients with IPD than in the control subjects (57.7 versus 28.8%, p = 0.003). No significant relationships were found between PD-related clinical characteristics (i.e. disease severity and duration, duration of exposure to levodopa) and the presence of PSNS. Significant correlations were found between the number of PSNS and physical functioning (Spearman’s Rho − 0.351), even after adjusting for age, gender and Hoehn and Yahr score.

Conclusion

Our results support the notion of a greater prevalence of PSNS in IPD patients as compared to the general population, which, at least in part, may be secondary to large and/or small fibre peripheral neuropathy. This warrants further investigation in larger studies that include detailed neurophysiological assessments.
Literatur
2.
Zurück zum Zitat Zis P, Sarrigiannis PG, Rao DG, Hewamadduma C, Hadjivassiliou M (2016) Chronic idiopathic axonal polyneuropathy: a systematic review. J Neurol 263:1903–1910CrossRefPubMed Zis P, Sarrigiannis PG, Rao DG, Hewamadduma C, Hadjivassiliou M (2016) Chronic idiopathic axonal polyneuropathy: a systematic review. J Neurol 263:1903–1910CrossRefPubMed
3.
Zurück zum Zitat Richardson JK, Hurvitz EA (1995) Peripheral neuropathy: a true risk factor for falls. J Gerontol A Biol Sci Med Sci 50:M211–M215CrossRefPubMed Richardson JK, Hurvitz EA (1995) Peripheral neuropathy: a true risk factor for falls. J Gerontol A Biol Sci Med Sci 50:M211–M215CrossRefPubMed
4.
Zurück zum Zitat Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ (2004) Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 21:976–982CrossRefPubMed Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ (2004) Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 21:976–982CrossRefPubMed
5.
Zurück zum Zitat Braak H, Braak E, Yilmazer D, Schultz C, de Vos RA, Jansen EN (1995) Nigral and extranigral pathology in Parkinson’s disease. J Neural Transm Suppl 46:15–31PubMed Braak H, Braak E, Yilmazer D, Schultz C, de Vos RA, Jansen EN (1995) Nigral and extranigral pathology in Parkinson’s disease. J Neural Transm Suppl 46:15–31PubMed
6.
Zurück zum Zitat Caligiore D, Helmich RC, Hallett M, Moustafa AA, Timmermann L, Toni I, Baldassarre G (2016) Parkinson’s disease as a system-level disorder. NPJ Parkinsons Dis 2:16025CrossRefPubMedPubMedCentral Caligiore D, Helmich RC, Hallett M, Moustafa AA, Timmermann L, Toni I, Baldassarre G (2016) Parkinson’s disease as a system-level disorder. NPJ Parkinsons Dis 2:16025CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Jellinger KA (1991) Pathology of Parkinson’s disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14:153–197CrossRefPubMed Jellinger KA (1991) Pathology of Parkinson’s disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14:153–197CrossRefPubMed
9.
Zurück zum Zitat Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P (2011) Parkinson’s disease: the non-motor issues. Parkinsonism Relat Disord 17:717–723CrossRefPubMed Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P (2011) Parkinson’s disease: the non-motor issues. Parkinsonism Relat Disord 17:717–723CrossRefPubMed
10.
Zurück zum Zitat Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, NMSS Validation Group (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord 26:399–406CrossRefPubMed Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, NMSS Validation Group (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord 26:399–406CrossRefPubMed
11.
Zurück zum Zitat Zis P, Erro R, Walton CC, Sauerbier A, Chaudhuri KR (2015) The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review. NPJ Parkinsons Dis 1:15013CrossRefPubMedPubMedCentral Zis P, Erro R, Walton CC, Sauerbier A, Chaudhuri KR (2015) The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review. NPJ Parkinsons Dis 1:15013CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Zis P, Rizos A, Martinez-Martin P, Pal S, Silverdale M, Sharma JC, Sauerbier A, Chaudhuri KR (2014) Non-motor symptoms profile and burden in drug naïve versus long-term Parkinson’s disease patients. J Parkinsons Dis 4:541–547PubMed Zis P, Rizos A, Martinez-Martin P, Pal S, Silverdale M, Sharma JC, Sauerbier A, Chaudhuri KR (2014) Non-motor symptoms profile and burden in drug naïve versus long-term Parkinson’s disease patients. J Parkinsons Dis 4:541–547PubMed
13.
Zurück zum Zitat Zis P, Martinez-Martin P, Sauerbier A, Rizos A, Sharma JC, Worth PF, Sophia R, Silverdale M, Chaudhuri KR (2015) Non-motor symptoms burden in treated and untreated early Parkinson’s disease patients: argument for non-motor subtypes. Eur J Neurol 22:1145–1450CrossRefPubMed Zis P, Martinez-Martin P, Sauerbier A, Rizos A, Sharma JC, Worth PF, Sophia R, Silverdale M, Chaudhuri KR (2015) Non-motor symptoms burden in treated and untreated early Parkinson’s disease patients: argument for non-motor subtypes. Eur J Neurol 22:1145–1450CrossRefPubMed
14.
Zurück zum Zitat Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRefPubMed Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRefPubMed
15.
Zurück zum Zitat Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653CrossRefPubMed Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653CrossRefPubMed
16.
Zurück zum Zitat Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L (2004) Movement Disorder Society Task Force on Rating Scales for Parkinson’s disease. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020–1028CrossRefPubMed Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L (2004) Movement Disorder Society Task Force on Rating Scales for Parkinson’s disease. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020–1028CrossRefPubMed
17.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442CrossRefPubMed Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442CrossRefPubMed
18.
Zurück zum Zitat Hays RD, Shapiro MF (1992) An overview of generic health-related quality of life measures for HIV research. Qual Life Res 1:91–97CrossRefPubMed Hays RD, Shapiro MF (1992) An overview of generic health-related quality of life measures for HIV research. Qual Life Res 1:91–97CrossRefPubMed
19.
Zurück zum Zitat Stewart AL, Hays RD, Ware JE Jr (1988) The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 26:724–735CrossRefPubMed Stewart AL, Hays RD, Ware JE Jr (1988) The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 26:724–735CrossRefPubMed
20.
Zurück zum Zitat Stewart JD, Low PA, Fealey RD (1992) Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve 15:661–665CrossRefPubMed Stewart JD, Low PA, Fealey RD (1992) Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve 15:661–665CrossRefPubMed
21.
Zurück zum Zitat Hays RD, Sherbourne CD, Mazel RM (1993) The RAND 36-Item Health Survey 1.0. Health Econ 2:217–227CrossRefPubMed Hays RD, Sherbourne CD, Mazel RM (1993) The RAND 36-Item Health Survey 1.0. Health Econ 2:217–227CrossRefPubMed
22.
Zurück zum Zitat Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281–1289CrossRefPubMed Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281–1289CrossRefPubMed
23.
Zurück zum Zitat Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, Feldman EL, DCCT/EDIC Research Group (2012) Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med 29:937–944CrossRefPubMedPubMedCentral Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, Feldman EL, DCCT/EDIC Research Group (2012) Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med 29:937–944CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Mukaka MM (2012) Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J 24:69–71PubMedPubMedCentral Mukaka MM (2012) Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J 24:69–71PubMedPubMedCentral
25.
Zurück zum Zitat Zis P, Grünewald RA, Chaudhuri RK, Hadjivassiliou M (2017) Peripheral neuropathy in idiopathic Parkinson’s disease: a systematic review. J Neurol Sci 378:204–209CrossRefPubMed Zis P, Grünewald RA, Chaudhuri RK, Hadjivassiliou M (2017) Peripheral neuropathy in idiopathic Parkinson’s disease: a systematic review. J Neurol Sci 378:204–209CrossRefPubMed
26.
Zurück zum Zitat Italian General Practitioner Study Group (IGPSG) (1995) Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology 45:1832–1836CrossRef Italian General Practitioner Study Group (IGPSG) (1995) Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology 45:1832–1836CrossRef
27.
Zurück zum Zitat Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C, Kessel B, Silverdale M, Todorova A, Sauerbier A, Odin P, Antonini A, Martinez-Martin P, EUROPAR and the IPMDS Non Motor PD Study Group (2015) King’s Parkinson’s disease pain scale, the first scale for pain in PD: an international validation. Mov Disord 30:1623–1631CrossRefPubMed Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C, Kessel B, Silverdale M, Todorova A, Sauerbier A, Odin P, Antonini A, Martinez-Martin P, EUROPAR and the IPMDS Non Motor PD Study Group (2015) King’s Parkinson’s disease pain scale, the first scale for pain in PD: an international validation. Mov Disord 30:1623–1631CrossRefPubMed
28.
Zurück zum Zitat Ceravolo R, Cossu G, Bandettini di Poggio M, Santoro L, Barone P, Zibetti M, Frosini D, Nicoletti V, Manganelli F, Iodice R, Picillo M, Merola A, Lopiano L, Paribello A, Manca D, Melis M, Marchese R, Borelli P, Mereu A, Contu P, Abbruzzese G, Bonuccelli U (2013) Neuropathy and levodopa in Parkinson’s disease: evidence from a multicenter study. Mov Disord 28:1391–1397CrossRefPubMed Ceravolo R, Cossu G, Bandettini di Poggio M, Santoro L, Barone P, Zibetti M, Frosini D, Nicoletti V, Manganelli F, Iodice R, Picillo M, Merola A, Lopiano L, Paribello A, Manca D, Melis M, Marchese R, Borelli P, Mereu A, Contu P, Abbruzzese G, Bonuccelli U (2013) Neuropathy and levodopa in Parkinson’s disease: evidence from a multicenter study. Mov Disord 28:1391–1397CrossRefPubMed
29.
Zurück zum Zitat Nolano M, Provitera V, Lanzillo B, Santoro L (2011) Neuropathy in idiopathic Parkinson disease: an iatrogenic problem? Ann Neurol 69:427–428CrossRefPubMed Nolano M, Provitera V, Lanzillo B, Santoro L (2011) Neuropathy in idiopathic Parkinson disease: an iatrogenic problem? Ann Neurol 69:427–428CrossRefPubMed
30.
Zurück zum Zitat Shahrizaila N, Mahamad UA, Yap AC, Choo YM, Marras C, Lim SY (2013) Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson’s disease? Parkinsonism Relat Disord 19:391–393CrossRefPubMed Shahrizaila N, Mahamad UA, Yap AC, Choo YM, Marras C, Lim SY (2013) Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson’s disease? Parkinsonism Relat Disord 19:391–393CrossRefPubMed
31.
Zurück zum Zitat Rajabally YA, Martey J (2013) Levodopa, vitamins, ageing and the neuropathy of Parkinson’s disease. J Neurol 260:2844–2848CrossRefPubMed Rajabally YA, Martey J (2013) Levodopa, vitamins, ageing and the neuropathy of Parkinson’s disease. J Neurol 260:2844–2848CrossRefPubMed
32.
Metadaten
Titel
Sensory neuropathic symptoms in idiopathic Parkinson’s disease: prevalence and impact on quality of life
verfasst von
Joy K. Adewusi
Marios Hadjivassiliou
Ana Vinagre-Aragón
Karen Ruth O’Connor
Aijaz Khan
Richard Adam Grünewald
Panagiotis Zis
Publikationsdatum
23.05.2018
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 3/2018
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-018-0947-3

Weitere Artikel der Ausgabe 3/2018

Acta Neurologica Belgica 3/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.